Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Biomira notified of patent allowance for Theratope

May 30, 1997

AltaRex initiates U.S. phase IIb trial with Ovarex

May 28, 1997

Bexxar as first-line therapy for non-Hodgkin's lymphoma

May 26, 1997

Preliminary phase II and phase I/II results for Allovectin-7

May 22, 1997

Preliminary results indicate potential for AML treatment

May 21, 1997

Techniclone reports promising results from brain cancer treatment study

May 21, 1997

Somatix reports promising results from melanoma vaccine trials

May 21, 1997

Ribi theraccine available for licensing outside Canada

May 19, 1997

NIH announces prospective grant of exclusive license for IL-13 receptor-specific chimeric antibodies

May 16, 1997

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...